Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of non-invasive fetal RhD genotyping on management costs of rhesus-D negative patients: results of a French pilot study.

European journal of obstetrics, gynecology, and reproductive biology - 1 May 2012

Benachi Alexandra, Delahaye Sophie, Leticee Nadia, Jouannic Jean-Marie, Ville Yves, Costa Jean-Marc

Abstract excerpt

OBJECTIVES: Fetal rhesus D (RhD) status determination using circulating cell-free fetal DNA from maternal plasma or serum is now recognized in Europe as a reliable and useful tool. A few countries are presently using this test in their management policy of rhesus D negative patients. The objective of this study is to evaluate the impact of this test on the costs of managing RhD-negative pregnant women, whether or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to France

Share to Genotyping Techniques

Share to Health Care Costs

Share to Pilot Projects

Share to Prenatal Diagnosis

Share to Rh-Hr Blood-Group System

Source

Identifiers

PMID: 22386678
DOI: 10.1016/j.ejogrb.2012.02.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of non-invasive fetal RhD genotyping on management costs of rhesus-D negative patients: results of a French pilot study.PMID 22386678Read ↗

Noninvasive Fetal RhD Blood Group Genotyping: A Systematic Review of Economic Evaluations.Semantic proximity Read ↗

Strategy for managing maternal variant RHD alleles in Rhesus D negative obstetric populations during fetal RHD genotyping.Semantic proximity Read ↗

Costs and Clinical Outcomes of Noninvasive Fetal RhD Typing for Targeted ProphylaxisSemantic proximity Read ↗

Non-invasive foetal RhD genotyping: A strategy for rationalizing anti-D immunoglobulin prophylaxis in RhD-negative pregnant women at the Hospital Italiano de Buenos Aires.Semantic proximity Read ↗

High-throughput, non-invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis.Semantic proximity Read ↗

Relevance and costs of RHD genotyping in women with a weak D phenotype.Semantic proximity Read ↗

Genotyping to prevent Rh disease: has the time come?Semantic proximity Read ↗

A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.Semantic proximity Read ↗

Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.Semantic proximity Read ↗

Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time.Semantic proximity Read ↗

[Non invasive fetal RhD genotyping using maternal blood: time for use in all RhD negative pregnant women].Semantic proximity Read ↗

Management of red cell alloimmunisation in pregnancy: the non-invasive monitoring of the disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.